MT-204

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMT-204
Drug Alias Nameanti-IL-2 antibody (Micromet)anti-IL-2 antibody (Amgen)MT-204
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionInterleukin-2 receptor antagonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsRejection of organ transplantationInflammationLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMicromet Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMicromet IncAmgen Inc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationInflammationLeukemia

Other Information

ATC CodeN/A
Related LinksN/A